BioPharma Credit Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Public Companies | 254,219 | 0.0214% |
Individual Insiders | 586,328 | 0.0493% |
Private Companies | 3,026,220 | 0.254% |
General Public | 62,784,046 | 5.28% |
Hedge Funds | 163,563,201 | 13.7% |
Institutions | 959,799,466 | 80.7% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
163,563,201 | US$144.6m | 0.64% | 0.25% | |||
91,624,538 | US$81.0m | 3.61% | 0.02% | |||
71,171,550 | US$62.9m | -0.32% | 62.93% | |||
66,054,360 | US$58.4m | -6.28% | 0.38% | |||
40,373,637 | US$35.7m | -1.21% | 0.01% | |||
37,798,626 | US$33.4m | -7.38% | no data | |||
35,701,705 | US$31.6m | 9.82% | 0.59% | |||
30,627,402 | US$27.1m | -3.83% | 0.02% | |||
28,772,809 | US$25.4m | 0.19% | 0.29% | |||
27,506,223 | US$24.3m | 6.59% | 0.01% | |||
25,319,717 | US$22.4m | -4.23% | 0.12% | |||
24,029,371 | US$21.2m | 0% | 0.06% | |||
23,214,975 | US$20.5m | 22% | 0.4% | |||
21,438,998 | US$19.0m | -2.93% | 0.02% | |||
19,095,254 | US$16.9m | -1.2% | 0.18% | |||
18,655,536 | US$16.5m | -3.07% | 0.01% | |||
17,453,103 | US$15.4m | -7.83% | no data | |||
15,369,904 | US$13.6m | 10.5% | 0.22% | |||
14,428,110 | US$12.8m | 52.6% | no data | |||
13,188,473 | US$11.7m | -4.6% | 0.07% | |||
12,800,000 | US$11.3m | 0% | 0.21% | |||
12,494,259 | US$11.0m | 0% | 4.36% | |||
12,312,192 | US$10.9m | -66.9% | no data | |||
12,309,066 | US$10.9m | 3.86% | 1.7% | |||
12,301,192 | US$10.9m | 418% | 10.15% |